vimarsana.com

O 19 1871 Fed Cir 2024 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Routine Optimization Does Not Necessarily Require A Disclosure Of Ranges Under The Results-Effective Variable Doctrine – Pfizer V Sanofi, No 19-1871 (Fed Cir 2024) - Patent

The results-effective variable doctrine is a caselaw principle where prior art disclosing the "general conditions of a claim" invokes a presumption of obviousness.

Pasteur incSk chemicals coFederal circuitRoutine optimization does not necessarily requirea disclosure of ranges under the results effective variable doctrine x2013 pfizerv sanofiO 19 1871 fed cir 2024Intellectual property

vimarsana © 2020. All Rights Reserved.